Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric sensititre yeastone method

Journal of Clinical Microbiology

Volumn 50, Issue 12, 2012, Pages 3921-3926

  Cantón, Emilia ^a   Pemán, Javier ^a   Hervás, David ^b   Iñiguez, Carmen ^c,d   Navarro, David ^e   Echeverría, Julia ^f   Martínez Alarcón, José ^g   Fontanals, Dionisia ^h   Gomila Sard, Bárbara ⁱ   Buendía, Buenaventura ^j   Torroba, Luis ^k   Ayats, Josefina ^l   Bratos, Angel ^m   Sánchez Reus, Ferran ⁿ   Fernández Natal, Isabel ^o   Alvarez, M ^p   Alcoba, Julia ^q   Borrell, Nuria ^r   Bratos, Miguel Ángel ^m   Camarena, Juan J ^s   Campos Herrero, Isolina ^t   Esperalba, Juliana ^u   Ezpeleta, Guillermo ^v   García, Julio ^w   García García, Inmaculada ^x   Garcíade La Pedrosa, Elia ^y   García Tapia, Ana María ^z   Guinea, Jesús ^aa   Guna, Remedios ^ab   Iglesias, Isabel ^ac   Linares Sicilia, María José ^ad   Marco, Francesc ^ae   Martín Mazuelos, Estrella ^af   Merino, Paloma ^ag   Miranda, Consuelo ^ah   Pazos, Carmen ^ai   Pérez Del Molino, Luisa ^aj   Porras, Aurelio ^ak   Ramírez, Inmaculada ^al   Rezusta, Antonio ^am   Roselló, Eva María ^an   Royo, Gloria ^ao   Rubio, Carmen ^ap   Ruiz Pérez De Pipaon, María Teresa ^aq   Suárez, Anabel ^ar   Velasco, David ^as   Yagüe, Genoveva ^at   more..

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b INSTITUTO DE INVESTIGACIÓN SANITARIA DEL HOSPITAL CLÍNICO SAN CARLOS IDISSC   (Spain)

^c Centro Superior de Investigacion en Salud Publica   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

^e HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^f HOSPITAL DONOSTIA   (Spain)

^g Hospital General   (Spain)

^h Servicio de Microbiología   (Spain)

ⁱ HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^j HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^k Universidad Pública de Navarra   (Spain)

^l HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^m HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

ⁿ HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^o Complejo Asistencial Universitario de León   (Spain)

^p HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^q HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^r HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^s HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^t HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^u HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^v HOSPITAL DE BASURTO   (Spain)

^w HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^x HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^y HOSPITAL RAMÓN Y CAJAL   (Spain)

^z HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^aa HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^ab HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^ac Xerencia de Xestion Integrada de Vigo SERGAS   (Spain)

^ad HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^ae HOSPITAL CLÍNIC   (Spain)

^af HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^ag HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^ah HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^ai Servicio de Microbiología Clínica Hospital S Pedro de Alcántara   (Spain)

^aj HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^ak HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^al HOSPITAL VIRGEN DE LA CONCHA   (Spain)

^am HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^an HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^ao Hospital General Universitario   (Spain)

^ap HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^aq HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^ar HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^as Hospital Lucus Augusti   (Spain)

^at HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; ECHINOCANDIN; FLUCYTOSINE; MICAFUNGIN;

ANALYTICAL PARAMETERS; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA ORTHOPSILOSIS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; COLORIMETRY; CONTROLLED STUDY; EPIDEMIOLOGICAL CUTOFF VALUE; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SENSITITRE YEASTONE; STATISTICAL ANALYSIS; WILD TYPE;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; ECHINOCANDINS; FLUCYTOSINE; HUMANS; MICROBIAL SENSITIVITY TESTS; MODELS, STATISTICAL; MYCOLOGY;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA ORTHOPSILOSIS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS;

EID: 84869206968     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01730-12     Document Type: Article

References (27)

1. Alexander BD, et al. 2007. Comparative evaluation of Etest and Sensititre YeastOne panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. J. Clin. Microbiol. 45:698-706. (Pubitemid 46427680)
2. Arendrup MC, et al. 2010. Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and Isosensitest media. Antimicrob. Agents Chemother. 54:426-439.
3. Cantón E, et al. 2005. Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates: correlation with results of NCCLS M27-A2 multicenter study. Antimicrob. Agents Chemother. 49:1604-1607. (Pubitemid 40463401)
4. Cantón E, et al. 2011. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia. Antimicrob. Agents Chemother. 55:5590-5596.
5. Douglas CM, et al. 1997. Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors. Antimicrob. Agents Chemother. 41:2471-2479. (Pubitemid 27467559)
6. Espinel-Ingroff A, et al. 2011. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Antimicrob. Agents Chemother. 55:5150-5154.
7. Espinel-Ingroff A, et al. 2004. Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp. J. Clin. Microbiol. 42:718-721. (Pubitemid 38222652)
8. Fraley C, Raftery AE. 2002. Model-based clustering, discriminant analysis, and density estimation. J. Am. Stat. Assoc. 97:611-631.
9. Fraley C, Raftery AE, Murphy TB, Scrucca L. 2012. MCLUST version 4 for R: normal mixture modeling for model-based clustering, classification, and density estimation. Technical report no. 597. Department of Statistics, University of Washington, Seattle, WA. http://www.stat.washington.edu/research/reports/2012/ tr597.pdf.
10. Garcia-Effron G, et al. 2011. Assessment of two new molecular methods for identification of Candida parapsilosis sensu lato species. J. Clin. Microbiol. 49:3257-3261.
11. Kahlmeter G, et al. 2003. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J. Antimicrob. Chemother. 52:145-148. (Pubitemid 36986868)
12. Kronvall G. 2010. Normalized resistance interpretation as a tool for establishing epidemiological MIC susceptibility breakpoints. J. Clin. Microbiol. 48:4445-4452.
13. Kurtz MB, et al. 1996. Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies. Infect. Immun. 64:3244-3251. (Pubitemid 26256172)
14. Meletiadis J, Mavridou E, Melchers WJG, Mouton JW, Verweij PE. 2012. Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis. Antimicrob. Agents Chemother. 56:2524-2529.
15. Pappas PG, et al. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535.
16. Pemán J, et al. 2012. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J. Antimicrob. Chemother. 67:1181-1187.
17. Perlroth J, Choi B, Spellberg B. 2007. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med. Mycol. 45:321-346. (Pubitemid 46839802)
18. Pfaller MA. 2011. Triazole and echinocandin wild-type MIC distributions with epidemiological cutoff values for six uncommon species of Candida. J. Clin. Microbiol. 49:3800-3804.
19. Pfaller MA, et al. 2011. Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution. J. Clin. Microbiol. 49:630-637.
20. Pfaller MA, et al. 2010. Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp. J. Clin. Microbiol. 48:52-56.
21. Pfaller MA, et al. 2008. Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin. J. Clin. Microbiol. 46:2155-2159.
22. Pfaller MA, et al. 2011. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretative criteria. Drug Resist. Updat. 14:164-176.
23. Pfaller MA, et al. 2012. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution. J. Clin. Microbiol. 50:2040-2046.
24. Pittet D, Li N, Woolson RF, Wenzel RP. 1997. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model. Clin. Infect. Dis. 24:1068-1078. (Pubitemid 27249003)
25. Rodríguez-Tudela JL, et al. 2008. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus. Antimicrob. Agents Chemother. 52:2468-2472. (Pubitemid 351915677)
26. Silverman BW. 1986. Density estimation for statistics and data analysis. Monographs on statistics and applied probability. Chapman and Hall, London, United Kingdom.
27. Turnidge J, Kahlmeter G, Kronvall G. 2006. Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values. Clin. Microbiol. Infect. 12:418-425.